» Articles » PMID: 15705891

Identification of OTX2 As a Medulloblastoma Oncogene Whose Product Can Be Targeted by All-trans Retinoic Acid

Overview
Journal Cancer Res
Specialty Oncology
Date 2005 Feb 12
PMID 15705891
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Through digital karyotyping of permanent medulloblastoma cell lines, we found that the homeobox gene OTX2 was amplified more than 10-fold in three cell lines. Gene expression analyses showed that OTX2 transcripts were present at high levels in 14 of 15 (93%) medulloblastomas with anaplastic histopathologic features. Knockdown of OTX2 expression by siRNAs inhibited medulloblastoma cell growth in vitro, whereas pharmacologic doses of all-trans retinoic acid repressed OTX2 expression and induced apoptosis only in medulloblastoma cell lines that expressed OTX2. These observations suggest that OTX2 is essential for the pathogenesis of anaplastic medulloblastomas and that these tumors may be amenable to therapy with all-trans-retinoic acid.

Citing Articles

Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours.

Seiboldt T, Zeiser C, Nguyen D, Celikyurekli S, Herter S, Najafi S Br J Cancer. 2024; 131(4):763-777.

PMID: 38942989 PMC: 11333474. DOI: 10.1038/s41416-024-02740-5.


Genes in Adult Tissues.

Terrinoni A, Micheloni G, Moretti V, Caporali S, Bernardini S, Minieri M Int J Mol Sci. 2023; 24(23).

PMID: 38069286 PMC: 10707059. DOI: 10.3390/ijms242316962.


The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.

Qin N, Paisana E, Picard D, Leprivier G, Langini M, Custodia C J Neurooncol. 2023; 165(2):329-342.

PMID: 37976029 PMC: 10689561. DOI: 10.1007/s11060-023-04508-y.


Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition.

Graziani V, Garcia A, Alcolado L, Le Guennec A, Henriksson M, Conte M Sci Rep. 2023; 13(1):1273.

PMID: 36690651 PMC: 9870962. DOI: 10.1038/s41598-023-27375-z.


Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery.

Fahmy S, Dawoud A, Zeinelabdeen Y, Kiriacos C, Daniel K, Eltahtawy O Cancers (Basel). 2022; 14(21).

PMID: 36358663 PMC: 9657918. DOI: 10.3390/cancers14215244.